Markedly decreasing azithromycin susceptibility of Neisseria gonorrhoeae, Germany, 2014 to 2021
Authors:
Open Access
- 5 August 2021
- journal article
- research article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 26 (31) , 2100616
Abstract
We monitored antimicrobial susceptibility developments of Neisseria gonorrhoeae in Germany from January 2014 to May 2021. The proportion of isolates with azithromycin minimum inhibitory concentrations above the epidemiological cut-off increased substantially, from 1.3% in 2014 to 12.2% in 2020. Preliminary data from 2021 showed a further rise (January to May: 20.7%). Therefore, azithromycin as part of the recommended dual therapy in Germany for non-adherent patients is challenged. Antimicrobial susceptibility testing in clinical practice is crucial and continuous susceptibility surveillance indispensable.Keywords
This publication has 13 references indexed in Scilit:
- Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre studyJournal of Antimicrobial Chemotherapy, 2021
- Emergence and dissemination of three mild outbreaks ofNeisseria gonorrhoeaewith high-level resistance to azithromycin in Barcelona, 2016–18Journal of Antimicrobial Chemotherapy, 2020
- 2020 European guideline for the diagnosis and treatment of gonorrhoea in adultsInternational Journal of STD & AIDS, 2020
- Dual antimicrobial therapy for gonorrhoea: what is the role of azithromycin?The Lancet Infectious Diseases, 2018
- Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational studyThe Lancet Infectious Diseases, 2018
- Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistanceBMC Infectious Diseases, 2018
- The novel 2016 WHONeisseria gonorrhoeaereference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterizationJournal of Antimicrobial Chemotherapy, 2016
- The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial PopulationsJournal of Clinical Microbiology, 2015
- High-level azithromycin-resistant Neisseria gonorrhoeae clinical isolate in France, March 2014Eurosurveillance, 2014
- Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and FutureClinical Microbiology Reviews, 2014